Journal article icon

Journal article

Methods for Evaluation of medical prediction Models, Tests And Biomarkers (MEMTAB) 2020 Symposium

Abstract:
The international MEMTAB symposium attracts researchers, healthcare workers, policy makers and manufacturers actively involved in the development, evaluation or regulation of tests, (bio) markers, models, tools, apps, devices or any other modality used for the purpose of diagnosis, prognosis, risk stratification or (disease or therapy) monitoring. Rapid technological progress coupled with the significant methodological complexities involved in developing, evaluating and implementing tests, markers, models or devices create formidable challenges. Yet these challenges are matched by unique opportunities, while the wide array of involved subdisciplines create an exciting milieu for the generation of new ideas and directions. The symposium aims to provide a forum for disseminating knowledge at the forefront of current research, and for stimulating dialogue that will propel future thought and endeavours to tackle the methodological and practical complexities facing the medical diagnostic, prognostic and monitoring field today. The virtual MEMTAB2020 event was specifically aimed at bringing together researchers from the diverse reaches of test evaluation, from in vitro test developers, industry and regulatory representatives, through methodologists, guideline developers and practising clinicians, in the hope of improving current understanding through knowledge exchange, and forging our diverse experiences and perspectives to delineate the future direction of diagnostic test research. In this respect, it is the only conference in the world that provides a platform dedicated to the investigation of medical tests, markers, models and other devices used for diagnosis prognosis and monitoring. This year's symposium focussed on the following conference themes: How to develop and apply prediction models and diagnostic tests High-dimensional data and genetic prediction Machine learning for evaluation of diagnostic tests, markers and prediction models Impact studies for diagnostic tests, markers and prediction models (including low resource settings) Systematic review and meta-analysis (including individual participant data) Big data, electronic health records, dynamic prediction How to quantify overdiagnosis With over 135 delegates and 88 accepted abstracts, we believe we were able to offer a very strong programme. It was our great pleasure to host this year's symposium and are looking forward to meeting you again at the next MEMTAB symposium!
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Authors


Publisher:
BioMed Central
Journal:
Diagnostic and Prognostic Research More from this journal
Volume:
5
Issue:
S1
Pages:
7-7
Article number:
7
Publication date:
2021-03-31
DOI:
EISSN:
2397-7523
ISSN:
2397-7523


Language:
English
Keywords:
Pubs id:
1195720
Local pid:
pubs:1195720
Source identifiers:
W4231943238
Deposit date:
2026-03-26
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP